Feb 5 (Reuters) - Recursion Pharmaceuticals Inc RXRX.O:
RECURSION PRESENTS PHASE 2 DATA FOR REC-994 IN CCM IN LATE-BREAKING ORAL PRESENTATION AT THE INTERNATIONAL STROKE CONFERENCE
Source text: ID:nGNX76R7sN
Further company coverage: RXRX.O
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.